Related references
Note: Only part of the references are listed.Final results of phase II trial of pegylated arginine deiminase (ADI-PEG20) in metastatic melanoma (MM).
L. G. Feun et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
VEGF-Induced Expression of miR-17-92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis
Aranzazu Chamorro-Jorganes et al.
CIRCULATION RESEARCH (2016)
Chromatophagy: Autophagy goes nuclear and captures broken chromatin during arginine-starvation
Hsing-Jien Kung et al.
AUTOPHAGY (2015)
Endothelial Metabolism Driving Angiogenesis Emerging Concepts and Principles
Anna Rita Cantelmo et al.
CANCER JOURNAL (2015)
PEGylation and pharmacological characterization of a potential antitumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida
Long Zhang et al.
CANCER LETTERS (2015)
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Fuming Qiu et al.
CANCER LETTERS (2015)
Endothelial Cell Metabolism in Normal and Diseased Vasculature
Guy Eelen et al.
CIRCULATION RESEARCH (2015)
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors
Benjamin K. Tomlinson et al.
CLINICAL CANCER RESEARCH (2015)
Metabolic pathway compartmentalization: an underappreciated opportunity?
Annalisa Zecchin et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
Arginine deprivation in cancer therapy
Lynn G. Feun et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells
Oula Khoury et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Manuele Rebsamen et al.
NATURE (2015)
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Shiran Rabinovich et al.
NATURE (2015)
Impacts of CD44 knockdown in cancer cells on tumor and host metabolic systems revealed by quantitative imaging mass spectrometry
Mitsuyo Ohmura et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2015)
Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy
S. Fulda et al.
ONCOGENE (2015)
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Shuyu Wang et al.
SCIENCE (2015)
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
Niramol Savaraj et al.
ONCOTARGET (2015)
Recombinant arginine-degrading enzymes in metabolic anticancer therapy and bioanalytics
Oleh V. Stasyk et al.
CELL BIOLOGY INTERNATIONAL (2015)
Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas
T. Gelb et al.
ONCOGENE (2015)
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
N. Cetinbas et al.
ONCOGENE (2015)
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
D. Zhao et al.
ONCOGENE (2015)
Autophagy regulates tissue overgrowth in a context-dependent manner
E. Perez et al.
ONCOGENE (2015)
Amino Acids and Immune Response: A Role for Cysteine, Glutamine, Phenylalanine, Tryptophan and Arginine in T-cell Function and Cancer?
Angelos K. Sikalidis
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Control of the translational machinery by amino acids
Christopher G. Proud
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Cell proliferation, potassium channels, polyamines and their interactions: a mini review
Thomas M. Weiger et al.
AMINO ACIDS (2014)
Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells
Ziyu Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
Jiangbo Liu et al.
BMC CANCER (2014)
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
Jennifer A. McAlpine et al.
BMC CANCER (2014)
Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging
Michael D. Allen et al.
CANCER RESEARCH (2014)
The role of cell signalling in the crosstalk between autophagy and apoptosis
Laurence A. Booth et al.
CELLULAR SIGNALLING (2014)
The multifaceted activity of VEGF in angiogenesis - Implications for therapy responses
Stijn Moens et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials
Anna Synakiewicz et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Angiogenesis revisited - role and therapeutic potential of targeting endothelial metabolism
Peter Stapor et al.
JOURNAL OF CELL SCIENCE (2014)
Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer
Rouzbeh Daylami et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis
Naoharu Takano et al.
MOLECULAR CANCER RESEARCH (2014)
Translation factors and ribosomal proteins control tumor onset and progression: how?
F. Loreni et al.
ONCOGENE (2014)
Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates
Monica Y. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy
Chun A. Changou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells
Z. Wang et al.
CELL DEATH & DISEASE (2014)
Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS
Shawn Elms et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Dietary requirements of nutritionally non-essential amino acids by animals and humans
Guoyao Wu et al.
AMINO ACIDS (2013)
Functional amino acids in nutrition and health
Guoyao Wu
AMINO ACIDS (2013)
The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targets
Jianzhou Cui et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis
Zhifei Cao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
Hsuan-Ying Huang et al.
CLINICAL CANCER RESEARCH (2013)
Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis
Peter Fraisl
EXPERIMENTAL CELL RESEARCH (2013)
What Occurs by Replacing Mn2+ with Co2+ in Human Arginase I: First-Principles Computational Analysis
Tiziana Marino et al.
INORGANIC CHEMISTRY (2013)
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
Thomas Yau et al.
INVESTIGATIONAL NEW DRUGS (2013)
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A. Ott et al.
INVESTIGATIONAL NEW DRUGS (2013)
Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase
Peter W. Szlosarek et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation
Min You et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction
Yan Long et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia
K. Morrow et al.
LEUKEMIA (2013)
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
Rita Tanios et al.
LEUKEMIA RESEARCH (2013)
Autophagy: A critical regulator of cellular metabolism and homeostasis
Stefan W. Ryter et al.
MOLECULES AND CELLS (2013)
AIF, reactive oxygen species, and neurodegeneration: A complex problem
Brian M. Polster
NEUROCHEMISTRY INTERNATIONAL (2013)
Upregulation of amino acid transporter expression induced by L-leucine availability in L6 myotubes is associated with ATF4 signaling through mTORC1-dependent mechanism
Jun-qiu Luo et al.
NUTRITION (2013)
Ambra1 at the crossroad between autophagy and cell death
G. M. Fimia et al.
ONCOGENE (2013)
The evolution of the TOR pathway and its role in cancer
E. M. Beauchamp et al.
ONCOGENE (2013)
Various modes of cell death induced by DNA damage
O. Surova et al.
ONCOGENE (2013)
Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells
Swati Mandal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Autophagy in tumour cell death
Robin L. Macintosh et al.
SEMINARS IN CANCER BIOLOGY (2013)
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
N. Syed et al.
CELL DEATH & DISEASE (2013)
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
Melissa M. Phillips et al.
CANCER RESEARCH AND TREATMENT (2013)
Leucine and mTORC1: a complex relationship
Kayleigh M. Dodd et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy
Yuqing Wang et al.
AUTOPHAGY (2012)
Depletion of L-arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes
Rosula Garcia-Navas et al.
AUTOPHAGY (2012)
A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells
Philippe Icard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
M. P. Kelly et al.
BRITISH JOURNAL OF CANCER (2012)
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
L. G. Feun et al.
BRITISH JOURNAL OF CANCER (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells
Wen-Bin Tsai et al.
CANCER RESEARCH (2012)
Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming
Shuo Qie et al.
CELL CYCLE (2012)
Cell death by autophagy: facts and apparent artefacts
D. Denton et al.
CELL DEATH AND DIFFERENTIATION (2012)
Targeting methionine auxotrophy in cancer: discovery & exploration
Vaidehi Agrawal et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
Patrick Raber et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Deprivation of arginine by recombinant human arginase in prostate cancer cells
Eddy C. Hsueh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
The autophagic paradox in cancer therapy
W. K. K. Wu et al.
ONCOGENE (2012)
Metabolic reprogramming of the tumor
L. M. R. Ferreira et al.
ONCOGENE (2012)
Arginine deprivation as a new treatment strategy for head and neck cancer
Cheng-Chih Huang et al.
ORAL ONCOLOGY (2012)
Agmatine (decarboxylated l-arginine): Physiological role and therapeutic potential
Gerhard J. Molderings et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Amino acid sensing and regulation of mTORC1
Lijun Yan et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Glutathione synthesis and its role in redox signaling
Hongqiao Zhang et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Amino acids and mTORC1: from lysosomes to disease
Alejo Efeyan et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis
B. Delage et al.
CELL DEATH & DISEASE (2012)
Cancer Cell Metabolism: One Hallmark, Many Faces
Jason R. Cantor et al.
CANCER DISCOVERY (2012)
The Transcription Factor Network Associated With the Amino Acid Response in Mammalian Cells
Michael S. Kilberg et al.
ADVANCES IN NUTRITION (2012)
Autophagic cell death Loch Ness monster or endangered species?
Han-Ming Shen et al.
AUTOPHAGY (2011)
Mitochondrial ROS generation for regulation of autophagic pathways in cancer
Zi-yue Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Apoptosis: why and how does it occur in biology?
Engin Ulukaya et al.
CELL BIOCHEMISTRY AND FUNCTION (2011)
Metabolic Flux and the Regulation of Mammalian Cell Growth
Jason W. Locasale et al.
CELL METABOLISM (2011)
Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment
Aude Carreau et al.
EXPERIMENTAL CELL RESEARCH (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
C. H. Eng et al.
ONCOGENE (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis
Tin-Lun Lam et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Bioengineered Human Arginase I with Enhanced Activity and Stability Controls Hepatocellular and Pancreatic Carcinoma Xenografts
Evan S. Glazer et al.
TRANSLATIONAL ONCOLOGY (2011)
Replacing Mn2+ with Co2+ in Human Arginase I Enhances Cytotoxicity toward L-Arginine Auxotrophic Cancer Cell Lines
Everett M. Stone et al.
ACS CHEMICAL BIOLOGY (2010)
l-Arginine stimulates proliferation and prevents endotoxin-induced death of intestinal cells
Bie Tan et al.
AMINO ACIDS (2010)
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines
Min You et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF)
Erik Norberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Pegylated arginase I: a potential therapeutic approach in T-ALL
Claudia P. Hernandez et al.
BLOOD (2010)
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
T-S Yang et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes
Yaroslav P. Bobak et al.
CELL BIOLOGY INTERNATIONAL (2010)
Mitochondrial control of caspase-dependent and -independent cell death
Ludivine A. Pradelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma
N. Savaraj et al.
CURRENT MOLECULAR MEDICINE (2010)
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Evan S. Glazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma
Eisuke Kobayashi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The mechanism of eukaryotic translation initiation and principles of its regulation
Richard J. Jackson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1
M. Djavaheri-Mergny et al.
ONCOGENE (2010)
Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthe tase-1
Evan S. Glazer et al.
SURGERY (2010)
Specificity of amino acid regulated gene expression: analysis of genes subjected to either complete or single amino acid deprivation
S. S. Palii et al.
AMINO ACIDS (2009)
Arginine metabolism and nutrition in growth, health and disease
Guoyao Wu et al.
AMINO ACIDS (2009)
ADI, autophagy and apoptosis Metabolic stress as a therapeutic option for prostate cancer
Randie H. Kim et al.
AUTOPHAGY (2009)
Arginine deiminase originating from Lactococcus lactis ssp lactis American Type Culture Collection (ATCC) 7962 induces G1-phase cell-cycle rrest and apoptosis in SNU-1 stomach adenocarcinoma cells
Jong-Eun Kim et al.
BRITISH JOURNAL OF NUTRITION (2009)
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
Sam-Mui Tsui et al.
CANCER CELL INTERNATIONAL (2009)
Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
T. L. Lam et al.
CANCER LETTERS (2009)
Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
Randie H. Kim et al.
CANCER RESEARCH (2009)
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
Linda J. Nicholson et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1 alpha/Sp4
Wen-Bin Tsai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The human neonatal small intestine has the potential for arginine synthesis; developmental changes in the expression of arginine-synthesizing and -catabolizing enzymes
Eleonore S. Kohler et al.
BMC DEVELOPMENTAL BIOLOGY (2008)
Arginine deprivation as a targeted therapy for cancer
L. Feun et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase
Tawnya L. Bowles et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Perivascular nitric oxide gradients normalize tumor vasculature
Satoshi Kashiwagi et al.
NATURE MEDICINE (2008)
Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells
Y. Chen et al.
CELL DEATH AND DIFFERENTIATION (2008)
Role of arginine metabolism in immunity and immunopathology
Elisa Peranzoni et al.
IMMUNOBIOLOGY (2007)
Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia
Changlian Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Autophagic and apoptotic response to stress signals in mammalian cells
Efisabetta Ferraro et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis
David D. Roberts et al.
CLINICAL CANCER RESEARCH (2007)
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion
Paul Ning-Man Cheng et al.
CANCER RESEARCH (2007)
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
Peter W. Szlosarek et al.
CLINICAL CANCER RESEARCH (2006)
The role of nitric oxide in tumour progression
Dai Fukumura et al.
NATURE REVIEWS CANCER (2006)
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase
LJ Shen et al.
CANCER LETTERS (2006)
Another way to die: autophagic programmed cell death
Y Tsujimoto et al.
CELL DEATH AND DIFFERENTIATION (2005)
Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies
PA Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle
C Mayeur et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels
S Kashiwagi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Polyamines: metabolism and implications in human diseases
C Moinard et al.
CLINICAL NUTRITION (2005)
Autophagy as a cell death and tumor suppressor mechanism
D Gozuacik et al.
ONCOGENE (2004)
Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine
MY Zhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2004)
Mitochondrial effectors in caspase-independent cell death
HK Lorenzo et al.
FEBS LETTERS (2004)
Polyamines and cancer: Old molecules, new understanding
EW Gerner et al.
NATURE REVIEWS CANCER (2004)
Arginine pathways and the inflammatory response: Interregulation of nitric oxide and polyamines: Review article
J Satriano
AMINO ACIDS (2004)
Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells
EJ Noh et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Controlling cancer by restricting arginine availability - arginine-catabolizing enzymes as anticancer
DN Wheatley
ANTI-CANCER DRUGS (2004)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies
F Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pegaspargase: a review of clinical studies
ML Graham
ADVANCED DRUG DELIVERY REVIEWS (2003)
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
IS Park et al.
BRITISH JOURNAL OF CANCER (2003)
Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
DN Wheatley et al.
BRITISH JOURNAL OF CANCER (2003)
Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
R Philip et al.
BRITISH JOURNAL OF CANCER (2003)
Arginine deprivation and tumour cell death: Arginase and its inhibition
DN Wheatley et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Agmatine modulates the in vivo biosynthesis and interconversion of polyamines and cell proliferation
M Dudkowska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells
YM Fu et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2003)
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
RK Jain
SEMINARS IN ONCOLOGY (2002)
Recombinant arginine deiminase as a potential anti-angiogenic agent
K Beloussow et al.
CANCER LETTERS (2002)
Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties
FW Holtsberg et al.
JOURNAL OF CONTROLLED RELEASE (2002)
A novel superfamily of enzymes that catalyze the modification of guanidino groups
H Shirai et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
D Fukumura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Characterization of arginine decarboxylase in rat brain and liver: Distinction from ornithine decarboxylase
S Regunathan et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis
H Gong et al.
LEUKEMIA (2000)
Single amino acid (arginine) restriction: Growth and death of cultured HeLa and human diploid fibroblasts
DN Wheatley et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2000)
Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells
L Scott et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
